(Q36269623)

13 August 2017

1 reference

title

Molecules involved in T-B co-stimulation and B cell homeostasis: possible targets for an immunological intervention in autoimmunity (English)

1 reference

13 August 2017

1 reference

2

Klaus Warnatz

1 reference

13 August 2017

Hans H Peter

1

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

Expert Opinion on Biological Therapy

13 August 2017

published in

1 reference

13 August 2017

volume

5 Suppl 1

1 reference

13 August 2017

page(s)

S61-71

1 reference

13 August 2017

cites work

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

OX40: targeted immunotherapy--implications for tempering autoimmunity and enhancing vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Systemic lupus erythematosus: a blissless disease of too much BLyS (B lymphocyte stimulator) protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

BTLA: a new inhibitory receptor with a B7-like ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Negative co-receptors on lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

New regulatory co-receptors: inducible co-stimulator and PD-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

The right place at the right time: novel B7 family members regulate effector T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Activation and inhibition of lymphocytes by costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

The immunological synapse for B-cell memory: the role of the ICOS and its ligand for the longevity of humoral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Mechanisms of H4/ICOS costimulation: effects on proximal TCR signals and MAP kinase pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

T-cell co-stimulation through B7RP-1 and ICOS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

ICOS is critical for CD40-mediated antibody class switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

ICOS co-stimulatory receptor is essential for T-cell activation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Impaired germinal center formation and recall T-cell–dependent immune responses in mice lacking the costimulatory ligand B7-H2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

ICOS deficiency in patients with common variable immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

The genetics of human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

BAFF mediates survival of peripheral immature B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

BAFF AND APRIL: a tutorial on B cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications for inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

T cell costimulation by the TNF ligand BAFF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

TACI and BAFF-R mediate isotype switching in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

The biochemistry and biology of BAFF, APRIL and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Impaired IgA class switching in APRIL-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Raised serum APRIL levels in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

B cells as therapeutic targets for rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Generation and characterization of LymphoStat‐B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

Mechanism of Action of Transmembrane Activator and Calcium Modulator Ligand Interactor-Ig in Murine Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.1.S61

21 January 2018

Identifiers

DOI

10.1517/14712598.5.1.S61

1 reference

13 August 2017

1 reference